Assignee
BORODIC GARY E
US·10 granted patents·9 pending applications·196 citations·filing 1989–2024
Top patents by PatentIndex Score
19 records- 0196US8926991B2Botulinum toxin and the treatment of primary disorders of mood and affectBORODIC GARY E·Filed 2006·Granted Jan 6, 2015·18 cites·19 claims
- 0291US8192979B2Compositions, methods and devices for preparing less painful Botulinum toxin formulationsBORODIC GARY E·Filed 2005·Granted Jun 5, 2012·11 cites·21 claims
- 0391US7270826B2Methods of using Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)BORODIC GARY E·Filed 2005·Granted Sep 18, 2007·9 cites·8 claims
- 0489US9066851B2Extended length botulinum toxin formulation for human or mammalian useBORODIC GARY E·Filed 2009·Granted Jun 30, 2015·10 cites·6 claims
- 0588US8679486B2High-potency botulinum toxin formulationsBORODIC GARY E·Filed 2010·Granted Mar 25, 2014·9 cites·8 claims
- 0683US11123411B2Method of treating macular degeneration using botulinum toxin-based pharmaceuticalsBORODIC GARY E·Filed 2017·Granted Sep 21, 2021·1 cites·18 claims
- 0777US9393291B2Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory bedsBORODIC GARY E·Filed 2013·Granted Jul 19, 2016·1 cites·18 claims
- 0876US5053005AChemomodulation of curvature of the juvenile spineBORODIC GARY E·Filed 1989·Granted Oct 1, 1991·137 cites·7 claims
- 0973US2024189402A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2024·Application pending·0 cites
- 1070US2009148476A1Chemodenervating pharmaceutical as anti-inflammatory agentBORODIC GARY E·Filed 2008·Application pending·0 cites
- 1165US11123412B2Method of treating macular degeneration using botulinum toxin-based pharmaceuticalsBORODIC GARY E·Filed 2018·Granted Sep 21, 2021·0 cites·10 claims
- 1264US2010278867A1Use of botulinum toxin for the treatment of chronic facial painBORODIC GARY E·Filed 2006·Application pending·0 cites
- 1361US2020368331A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2020·Application pending·0 cites
- 1458US2014315820A1High-Potency Botulinum Toxin FormulationsBORODIC GARY E·Filed 2014·Application pending·0 cites
- 1549US11096993B2Method of treating macular degeneration using botulinum toxin-based pharmaceuticalsBORODIC GARY E·Filed 2018·Granted Aug 24, 2021·0 cites·18 claims
- 1646US2020046813A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2018·Application pending·0 cites
- 1745US2009324647A1Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of UseBORODIC GARY E·Filed 2006·Application pending·0 cites
- 1842US2018344806A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2018·Application pending·0 cites
- 1939US2011319944A1Submuscular Facial Fixation (Myo-Osseous Fixation) Using Microincision Microscrew Device, Injectable Glues and Adhesives, and Method and Device for Therapy of Migraine and Related HeadachesBORODIC GARY E·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →